Ophthalmic timolol treatment causing altered hypoglycemic response in a diabetic patient.
A diabetic patient experienced a dangerous alteration in hypoglycemic symptoms during treatment with ophthalmic timolol maleate. Before and after timolol therapy, hypoglycemic reactions were characterized by sweating, uneasiness, and prompt resolution with glucose treatment. During timolol therapy, reactions were characterized by a changed mental status (including seizures on occasion) and a relative resistance to glucose treatment. Caution must be exercised in the use of even topically applied beta-adrenergic blockers in diabetic patients who are prone to hypoglycemia.
D000368:Aged; D048909:Diabetes Complications; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology*; D008297:Male; D011412:Propanolamines / Q000009:adverse effects*; D011605:Psychoses, Substance-Induced / Q000209:etiology; D012640:Seizures / Q000139:chemically induced; D013999:Timolol / Q000009:adverse effects*
D011412:Propanolamines; D013999:Timolol